![]() |
![]() |
|||||||||||
![]() |
||||||||||||
![]() |
||||||||||||
In July 2009, the SEC filed a complaint in the United States District Court for the Southern District of California against Medical Capital Holdings, Inc., its principals, and various entities through which it raised capital. Since 2003, Medical Capital has raised over $2.2 billion by selling preferred stock in associated several purpose corporations (SPCs). These securities were sold through a number of broker-dealer firms including Securities America, Inc. Medical Capital appears to have made numerous material misrepresentations to its investors in connection with the sale of securities. For example, it represented that none of its SPCs had defaulted on principal and/or interest payments after its SPCs had in fact defaulted on nearly $1Billion in notes. In addition, Medical Capital used its investors’ capital to pay administrative fees after representing that there would be no such fees. Blau & Malmfeldt is prepared to file FINRA arbitration actions on behalf of investors who have lost their investment in Medical Capital Holdings, Inc., Medical Capital Corporation and its associated SPCs, including Medical Provider Corporation IV. If you have suffered losses through Medical Capital, please contact Blau & Malmfeldt to schedule a free consultation. We are focused upon serving investors. We promise that you will have a better understanding of your rights and your options after you speak to us. Your consultation will be free of charge. Blau & Malmfeldt is a law firm that primarily represents investors in arbitration and litigation against securities and commodity futures industry members. We have recovered millions of dollars on behalf of our investor clients. Our clients are located throughout the United States. Contingency fee schedules are available. Blau & Malmfeldt 140 South Dearborn Street, Suite 1610 Chicago, Illinois 60603-5202 Tel: (312) 443-1600 Fax: (312) 443-1665 |
||||||||||||
![]() |
||||||||||||
|
© Blau & Malmfeldt |
||||||||||||